Evidence map›Paper›PMID 18852248›Full record

ArticleInfection and immunity2008

Identification of concomitant infection with Chlamydia trachomatis IncA-negative mutant and wild-type strains by genomic, transcriptional, and biological characterizations.

Robert J Suchland, Brendan M Jeffrey, Minsheng Xia, Ajay Bhatia, Hencelyn G Chu, Daniel D Rockey, Walter E Stamm

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.0field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Infection and immunity · 2020
    Article
  8. Chromosomal Recombination Targets inJournal of bacteriology · 2019
    Article
  9. Article
  10. Article
  11. Development of a Proximity Labeling System to Map theFrontiers in cellular and infection microbiology · 2017
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Robert J SuchlandDivision of Allergy and Infectious Disease, Department of Medicine, University of Washington, Seattle, Washington, USA.
Brendan M Jeffrey
Minsheng Xia
Ajay Bhatia
Hencelyn G Chu
Daniel D Rockey
Walter E Stamm
Oregon State University · USUniversity of Washington · USCorixa Corporation · US

Funding

University of Washington STI-TM Cooperative Research CtrU19AI031448 · NIAID · UNIVERSITY OF WASHINGTON · PI HOLMES, KING K. · 1995 to 2010
$15.2M
CHLAMYDIA TRACHOMATIS INCA MUTANTSR01AI048769 · NIAID · OREGON STATE UNIVERSITY · PI ROCKEY, DANIEL D · 2001 to 2005
$1.7M
UNIVERSITY OF WASHINGTON STD COOPERATIVE RESEARCH CENTERU01AI031448 · NIAID · UNIVERSITY OF WASHINGTON · PI HOLMES, KING KENNARD · 1991 to 1994
–
NIAID NIH HHS AI031448NIAID NIH HHS AI48769NIAID NIH HHS R01 AI048769NIAID NIH HHS U19 AI031448
6 · The paper itself

Abstract

Clinical isolates of Chlamydia trachomatis that lack IncA on their inclusion membrane form nonfusogenic inclusions and have been associated with milder, subclinical infections in patients. The molecular events associated with the generation of IncA-negative strains and their roles in chlamydial sexually transmitted infections are not clear. We explored the biology of the IncA-negative strains by analyzing their genomic structure, transcription, and growth characteristics in vitro and in vivo in comparison with IncA-positive C. trachomatis strains. Three clinical samples were identified that contained a mixture of IncA-positive and -negative same-serovar C. trachomatis populations, and two more such pairs were found in serial isolates from persistently infected individuals. Genomic sequence analysis of individual strains from each of two serovar-matched pairs showed that these pairs were very similar genetically. In contrast, the genome sequence of an unmatched IncA-negative strain contained over 5,000 nucleotide polymorphisms relative to the genome sequence of a serovar-matched but otherwise unlinked strain. Transcriptional analysis, in vitro culture kinetics, and animal modeling demonstrated that IncA-negative strains isolated in the presence of a serovar-matched wild-type strain are phenotypically more similar to the wild-type strain than are IncA-negative strains isolated in the absence of a serovar-matched wild-type strain. These studies support a model suggesting that a change from an IncA-positive strain to the previously described IncA-negative phenotype may involve multiple steps, the first of which involves a translational inactivation of incA, associated with subsequent unidentified steps that lead to the observed decrease in transcript level, differences in growth rate, and differences in mouse infectivity.

Indexed as

Gene Expression Regulation, BacterialAnimalsBacterial ProteinsBase SequenceBlotting, NorthernChlamydiaceae InfectionsChlamydia trachomatisFemaleHumansMembrane ProteinsMiceMicroscopy, FluorescenceMolecular Sequence DataPhenotypePolymorphism, GeneticReverse Transcriptase Polymerase Chain ReactionBacterial ProteinsIncA protein, Chlamydia trachomatisMembrane Proteins

Identifiers

PMID18852248
PMCPMC2583591
OpenAlexW2115510515

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.